抗糖尿病药物位干扰调节了对大动脉动脉瘤的敏感性
Ranran Kong1, Zhihui Kuang2, Xia Wu3
1Department of Cardiology, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Nanfang Hospital, Southern Medical University, Guangzhou, China.
European journal of pharmacology
|November 20, 2025
概括
甲胺是一种甲胺.
科学领域:
- 遗传学 是一个遗传学.
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 大动脉动脉瘤 (AA),包括腹部 (AAA) 和胸部 (TAA) 类型,是缺乏有效预防治疗的危急疾病.
- 虽然抗糖尿病药物对AA治疗有希望,但仍需要确的证据.
- 确定有效的抗糖尿病药物对AAs对于临床应用至关重要.
研究的目的:
- 研究抗糖尿病药物点在预防大动脉动脉瘤方面的潜力.
- 为了确定特定的抗糖尿病药物标和AA风险之间的因果关系.
- 探索这些目标的保护作用背后的机制.
主要方法:
- 药物标门德尔随机化 (MR) 用大规模的全基因组关联研究 (GWAS) 来研究AAA/TAA和基因表达数据.
- 分析包括逆变量加权MR,介导MR,局部化,全现象MR和动物实验.
- 这些方法用于确认因果关系,并评估已识别的基因的变性.
主要成果:
- 甲胺的标PRKAB1已证明对AAA和TAA都有保护作用.
- 调解分析表明,PRKAB1的作用部分是由高密度脂蛋白和甘油三水平调解的.
- 胰岛素受体也被发现可以降低TAA的风险.
结论:
- PRKAB1在预防大动脉动脉瘤形成方面发挥着重要作用,主要是通过脂质调节.
- 胰岛素受体可能有助于减少胸腔大动脉动脉瘤的发生率.
- 这些发现为通过调节抗糖尿病药物标开发有针对性的AA疗法提供了早期证据.
更多相关视频
07:21Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
39.0K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
901
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K